APN:JSE
Aspen Pharmacare Holdings Ltd
ZACÂ 16,639.00
arrow_downward
-0.47%(-78.00) 1D
Nov 6, 5:03:57 PM GMT+2 · ZAC
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for APN...
Open
ZACÂ 16,717.00
High
ZACÂ 16,717.00
Low
ZACÂ 16,160.00
Mkt. cap
72.03B
Avg. vol.
1.56M
Volume
530.44K
Dividend
1.39%
Quarterly dividend
ZACÂ 58.00
Ex-dividend date
Oct 7, 2026
52-wk high
ZACÂ 16,891.00
52-wk low
ZACÂ 9,070.00
EPS
-ZACÂ 2.00
Shares outstanding
432.92M
No. of employees
7K
Open
ZACÂ 16,717.00
High
ZACÂ 16,717.00
Low
ZACÂ 16,160.00
Mkt. cap
72.03B
Avg. vol.
1.56M
Volume
530.44K
Dividend
1.39%
Quarterly dividend
ZACÂ 58.00
Ex-dividend date
Oct 7, 2026
52-wk high
ZACÂ 16,891.00
52-wk low
ZACÂ 9,070.00
EPS
-ZACÂ 2.00
Shares outstanding
432.92M
No. of employees
7K
News stories
From web sources and news partners
Yahoo Finance
·
15 minutes ago
Sell Alert: 5 High-Profile Stocks Just Dumped by Top Analysts
Exchange Rates UK
·
1 hour ago
S&P 500 Slide Exposes Large Stock Moves Hidden Beneath The Index
Benzinga
·
2 hours ago
Dow Jones and S&P 500 Outlook: Stock Market News To Watch This Week
BBN Times
·
1 day ago
S&P 500 Futures End the Week Near 7,402 as Traders Brace for CPI
Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. The largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016, Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for five years in the European Union. Wikipedia
About Aspen Pharmacare Holdings Ltd
CEOStephen Saad
Employees7.45K
Founded1850
HeadquartersDurban, KwaZulu-Natal, South Africa
SectorHealth Care
IndustryPharmaceutical industry
Websiteaspenpharma.com